Post Exposure Prophylaxis in Healthcare Workers Exposed to COVID-19 Patients
NCT04437693
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
UNKNOWN
Status
500
Enrollment
INDUSTRY
Sponsor class
Conditions
COVID 19
Interventions
DRUG:
Hydroxychloroquine
Sponsor
Hamad Medical Corporation